PCMM | 2015

July 1, 2015

Yoandris del Toro Duany, Falong Lu and Xianchi Dong awarded Charles A. King Trust Postdoctoral Fellowships

Congratulations to Dr. Yoandris del Toro Duany from the Hur Lab, Dr. Falong Lu from the Zhang lab and Dr. Xianchi Dong from the Springer lab. Each was awarded a 2-year grant by the Charles A. King Trust Postdoctoral Research Fellowship Program.

June 22, 2015

Denisa Wagner Received the 2015 Grant Medal, the highest award of the International Society on Thrombosis and Haemostasis (ISTH)

Wagner, a former member of the ISTH Council (2004-10), is the Edwin Cohn Professor of Pediatrics at Harvard Medical School in Boston. Among her many accomplishments, Wagner is credited with defining the cell biology of von Willebrand factor and uncovering the biological importance of P-selectin as well as the importance of neutrophil extracellular traps (NETs) in thrombosis and sterile inflammation. Wagner and her colleagues were the first laboratory to study thrombosis, using the now widespread technique of intravital microscopy, in genetically-engineered mice.

The Robert P. Grant Medal is the highest award of the ISTH. It is presented at each biennial Congress of the Society to a recipient selected for outstanding service or accomplishment who has promoted the goals of the Society. This award may be for research achievement, for organizational activities, for important public recognition and support of research activities, for facilitation of institutional cooperation and communications, for unusual teaching or educational initiatives, or for the development of concepts which result in a clearer understand of the meaning of research data.

Read More

June 11, 2015

The Pew Charitable Trusts awarded Dr. Karla Meza-Sosa the 2015 Pew Latin American Fellowships in the Biomedical Sciences 

As a Pew fellow Dr. Meza-Sosa will study the molecular mechanisms by which a long-non coding RNA mediates the cellular response to genotoxic stress. This research will shed new light into the molecular mechanisms that determine cell fate outcome (apoptosis, cell cycle arrest or senescence), and provide new insight into the mechanisms underlying gene expression control exerted by lncRNAs.

May 22, 2015

Dr. Frederick W. Alt  received the 2015 Katharine Berkan Judd Award from the Memorial Sloan Kettering Cancer Center.  

This award is given annually for Distinguished Achievement in Biomedical Research.   The Judd Award was established in 1936 by Mrs. Judd.   She had the foresight and vision to realize that, in the future, scientists would make great strides towards the control and understanding of cancer through basic discovery.   Toward that end, she provided that a portion of her estate be designated as the Katharine Berkan Judd Cancer Fund.  Dr. Alt was selected to receive the Judd award this year for his contributions to understanding DNA repair pathways the mediate recombination in the immune system, and the relevance of these pathways to chromosomal translocation and oncogenesis.


May 21, 2015

Dr. Sun Hur received a prestigious Investigators in the Pathogenesis of Infectious Disease award from the Burroughs Wellcome Fund. 

During this 5-year award Dr. Hur will examine the mechanisms by which the protein displacement activity of RIG-I and MDA5 exert signaling-independent antiviral functions.

The Burroughs Wellcome Fund is an independent private foundation dedicated to advancing the biomedical sciences by supporting research and other scientific and educational activities.

 April 29, 2015

Frederick Alt honored with 2015 Szent-Györgyi Prize for Progress in Cancer Research

Frederick Alt, PhD, director of the Program in Cellular and Molecular Medicine at Boston Children's Hospital, has been honored with the 2015 Szent-Györgyi Prize for Progress in Cancer Research. Awarded by the National Foundation for Cancer Research (NFCR), the prize recognizes Alt's groundbreaking work on the genetic nature of cancer, research that laid the foundation for our modern understanding of cancer and for the current revolution in personalized, targeted cancer treatment.

The Keynote speech at the award ceremony was delivered by Edward Markey, United States Senator for Massachusetts. 

Read more

 April 28, 2015

Congratulations to Professor Hao Wu for being elected to the National Academy of Sciences

The National Academy of Sciences (NAS) announced their election of 84 new members and 21 foreign associates in recognition of their distinguished achievements in original research. Among these new members is Dr. Hao Wu, Asa and Patricia Springer Professor in the
Department of Biological Chemistry and Molecular Pharmacology at Harvard Medical School, and Senior Investigator in the Program in Cellular and Molecular Medicine at Boston Children's Hospital.

 April 13, 2015

Congratulations to Fred Alt, Recipient of the 44th Rosenstiel Award for Distinguished Work in Biomedical Science

The 44th Rosenstiel Award for Distinguished Work in Biomedical Science has been awarded to Dr. Frederick W. Alt, the Director of the Program in Cellular and Molecular Medicine at Boston Children’s Hospital. He is also Charles A. Janeway Professor of Pediatrics and Professor of Genetics, Harvard Medical School and Investigator of the Howard Hughes Medical Institute. Dr. Alt is honored for his pioneering work in elucidating the mechanisms of genome rearrangements in immune and cancer cells.

Read More


March 12, 2015

Dr. Heng Ru was awarded the Cancer Research Institute Irvington Postdoctoral Fellowship

During the three-year fellowship, Dr. Ru, a Postdoctoral Fellow in the Wu lab,  will investigate the catalytic and regulatory mechanism of the recombination-activating gene (RAG) protein complex, which is fundamental to our understanding of V(D)J recombination and generation of antibody diversity. Genetic mutations and dysregulation of RAGs are associated with many human diseases, such as severe combined immunodeficiency, T cell acute lymphoblastic leukemia, chronic myelogenous leukemia, systemic lupus erythematosus, as well as malignancies outside the immune system, including colorectal cancer. The funded project will reveal the molecular basis for the pathological relationships between RAGs and these diseases and provide new insights into their treatment.

March 3, 2015

Sun Hur was awarded the 2015 Vilcek Prize for Creative Promise in Biomedical Science

Sun Hur Ph.D was awarded the 2015 Vilcek Prize for Creative Promise in Biomedical Science. The Vilcek Prizes for Creative Promise were established in 2009 to encourage and support young immigrants who have already demonstrated exceptional achievements, and who often face significant challenges early in their careers.

Read more